Study guide
9.3 Pregnancy, Pediatrics, Geriatrics & Organ Impairment
DHA Pharmacist Licensing Assessment PHO5481
Track your progress as you read
Finished sections get a check mark.
1 Exam Overview & Licensing Pathway
1.1 Current Exam Facts & Format 1.2 Eligibility, PQR & the Sheryan Application Process 1.3 Study Strategy & Test-Day Plan
2 Cardiovascular Pharmacology
2.1 Antihypertensives & RAAS Agents 2.2 Heart Failure & Antiarrhythmic Drugs 2.3 Lipid-Lowering & Antianginal Agents
3 Endocrine & Metabolic Pharmacology
3.1 Insulin & Oral Antidiabetic Agents 3.2 Thyroid, Bone & Calcium Agents 3.3 Corticosteroids & Other Hormonal Agents
4 Anti-Infective Pharmacology
4.1 Beta-Lactam Antibiotics 4.2 Non-Beta-Lactam Antibacterials 4.3 Antifungals, Antivirals & Antituberculars
5 CNS, Psychiatric & Pain Pharmacology
5.1 Psychiatric Pharmacology 5.2 Antiepileptics & Neurologic Agents 5.3 Analgesics: NSAIDs, Opioids & Migraine
6 Respiratory, GI & Hematology Pharmacology
6.1 Respiratory Pharmacology 6.2 Gastrointestinal Pharmacology 6.3 Anticoagulants, Antiplatelets & Hematology Agents
7 Pharmaceutical Care: Cardiometabolic Disease
7.1 Diabetes Management & Counseling 7.2 Hypertension & Dyslipidemia Management 7.3 Heart Failure & Anticoagulation Management
8 Pharmaceutical Care: Respiratory, Rheumatology & Infection
8.1 Asthma & COPD Management 8.2 Gout, Pain & Rheumatologic Care 8.3 Infection Management & Antimicrobial Stewardship
9 Counseling, Monitoring & Special Populations
9.1 Patient Counseling, Adherence & Health Literacy 9.2 Therapeutic Monitoring & Laboratory Interpretation 9.3 Pregnancy, Pediatrics, Geriatrics & Organ Impairment 9.4 Pharmacoeconomics & Formulary Decision Making
10 Pharmaceutical Calculations I
10.1 Concentration, Ratio & Percentage Strength 10.2 Weight-Based & BSA Dosing 10.3 Dilution, Concentration & Alligation
11 Pharmaceutical Calculations II
11.1 Infusion Rates & IV Flow Calculations 11.2 Dispensing Quantities & Days' Supply 11.3 Compounding Calculations, Isotonicity & Milliequivalents
12 UAE Pharmacy Law & Regulation
12.1 UAE Regulatory Framework & Licensing Authorities 12.2 Medicine Registration, Pricing & Supply Chain 12.3 Prescription Requirements & Validity
13 Controlled Drugs, Ethics & Pharmacovigilance
13.1 Controlled & Semi-Controlled Medicines in the UAE 13.2 Ethics, Confidentiality & Generic Substitution 13.3 Pharmacovigilance, Recall & Medicine Disposal
14 Pharmacokinetics I: ADME
14.1 Absorption & Bioavailability 14.2 Distribution & Protein Binding 14.3 Metabolism & Elimination
15 Pharmacokinetics II: Kinetics, Dosing & TDM
15.1 Half-Life, Clearance & Kinetic Order 15.2 Loading & Maintenance Dosing 15.3 Therapeutic Drug Monitoring
16 OTC Medicines & Self-Care
16.1 Cough, Cold & Allergic Rhinitis 16.2 GI Self-Care: Heartburn, Constipation & Diarrhoea 16.3 Pain & Fever Self-Care 16.4 Referral Red Flags, Emergency Contraception & Skin
17 Medication Safety
17.1 High-Alert Medications & Error-Prone Abbreviations 17.2 Medication Reconciliation & Duplicate Therapy 17.3 Adverse Drug Reactions & Hypersensitivity Recognition
18 Sterile & Nonsterile Compounding
18.1 Aseptic Technique & Compounding Environments 18.2 Parenteral, TPN & Cytotoxic Preparation 18.3 Nonsterile Compounding
19 Pharmaceutics, Biopharmaceutics & Toxicology
19.1 Dosage Form Design & the Biopharmaceutics Classification System 19.2 Dissolution & Excipients 19.3 Toxicology: Poisoning Recognition & Antidotes
20 Infection Control, Natural Products, Medicinal Chemistry & Pharmacogenomics
20.1 Infection Control & Immunization 20.2 Pharmacognosy & Dietary Supplements 20.3 Medicinal Chemistry Essentials 20.4 Clinical Pharmacogenomics
9.3 Pregnancy, Pediatrics, Geriatrics & Organ Impairment
Key Takeaways Explain This Topic AI
Paracetamol is the first-line analgesic in pregnancy; ACE inhibitors, ARBs, statins, valproate, warfarin, tetracyclines, isotretinoin and methotrexate must be avoided
Avoid trimethoprim in the first trimester and nitrofurantoin at term; first-line nausea treatment is pyridoxine with or without doxylamine
Pediatric dosing is weight-based (mg/kg) and capped at the adult dose; avoid aspirin (Reye's syndrome), codeine under 12 years, tetracyclines under 8 years, and chloramphenicol in neonates
In older adults, a normal serum creatinine can hide significant renal decline — always estimate creatinine clearance before dosing renally cleared drugs like digoxin
In renal impairment the loading dose usually stays the same (it depends on volume of distribution) while the maintenance dose is reduced (it depends on clearance)
Last updated: August 2026
Pregnancy
The old FDA letter categories (A, B, C, D, X) have been replaced by a narrative labelling system (the Pregnancy and Lactation Labeling Rule) , so modern practice weighs the risk–benefit balance for each drug rather than memorising letters. General principles: use the fewest drugs at the lowest effective dose, avoid non-essential medicines in the first trimester (organogenesis), and never withhold clearly necessary treatment. Folic acid 400 micrograms daily is recommended pre-conception and through the first trimester; 5 mg daily is used in higher-risk women (previous neural tube defect, diabetes, or antiepileptic drugs such as valproate or carbamazepine).
Drugs to Avoid in Pregnancy
Drug/class Principal fetal risk
ACE inhibitors and ARBs Fetal renal failure, oligohydramnios, skull hypoplasia (second/third trimester fetopathy)
- Statins Cholesterol synthesis is essential for fetal development; discontinue in pregnancy
- Valproate Neural tube defects and impaired neurodevelopment — avoid whenever any alternative exists
- Warfarin Fetal warfarin syndrome (nasal hypoplasia, stippled epiphyses) and bleeding
- Tetracyclines Permanent tooth discoloration and effects on bone growth
- Isotretinoin Severe craniofacial, cardiac and CNS malformations (retinoid embryopathy)
- Methotrexate Folate antagonist — teratogenic and abortifacient
- Common Pregnancy Problems
Analgesia: paracetamol is first-line at the lowest effective dose. Avoid NSAIDs, especially in the third trimester (premature closure of the ductus arteriosus, oligohydramnios).
Nausea and vomiting: start with dietary measures; first-line drug therapy is pyridoxine (vitamin B6) with or without doxylamine . Ondansetron is generally reserved for refractory cases because of a possible small increase in oral clefts with first-trimester use and QT-prolongation cautions.
Urinary tract infection: all bacteriuria in pregnancy is treated. Avoid trimethoprim in the first trimester (folate antagonism — neural tube defect risk) and avoid nitrofurantoin at term (risk of neonatal haemolytic anaemia). Typical culture-guided choices include amoxicillin-clavulanate or a cephalosporin such as cefalexin.
Breastfeeding
Drug transfer into milk is greatest for drugs that are small (low molecular weight), lipophilic, minimally protein-bound, and weakly basic . As a rule of thumb, a relative infant dose below 10% of the maternal weight-adjusted dose is considered compatible with breastfeeding. Practical advice: choose the shortest-acting agent, dose just after a feed or before the infant's longest sleep, and check a specialist resource (e.g. LactMed) rather than guessing. Codeine is avoided because ultra-rapid CYP2D6 metabolisers convert it to morphine at dangerous rates.
Pediatrics
Children are dosed by weight (mg/kg) , with the total capped at the adult dose; body surface area is reserved for specialist uses such as oncology. Use oral syringes for liquids to ensure accurate measurement, and match the formulation to the age band (suspensions and dispersible tablets for young children). Physiology matters too: neonates have immature hepatic enzymes and renal function, so drug clearance is reduced and dosing intervals are extended, while young children often clear drugs faster per kilogram than adults. Always double-check the arithmetic on a paediatric dose — a tenfold error from a misplaced decimal is a recognised cause of serious harm.
Absolute or near-absolute paediatric avoidances:
Aspirin — avoid in children and adolescents under 16 with viral illness because of Reye's syndrome (acute encephalopathy with liver failure).
Codeine — contraindicated under 12 years and avoided in 12–18-year-olds with respiratory conditions; ultra-rapid CYP2D6 metabolisers risk morphine toxicity.
Tetracyclines — avoid under 8 years (tooth discoloration, enamel hypoplasia).
Chloramphenicol — avoid in neonates: immature glucuronidation causes accumulation and grey baby syndrome (circulatory collapse, cyanosis).
Fluoroquinolones — generally avoided in children because of cartilage concerns, with defined specialist exceptions.
Geriatrics
Polypharmacy (commonly defined as five or more medicines) drives adverse events, interactions and prescribing cascades , where a side effect is misread as a new disease and treated with another drug. Screening tools frequently examined are the Beers criteria (American Geriatrics Society list of potentially inappropriate medicines in older adults) and STOPP/START — STOPP flags potentially inappropriate prescriptions, START flags omitted but indicated therapies. Watch the anticholinergic burden (cognitive impairment, constipation, urinary retention, blurred vision, falls) from drugs such as oxybutynin, tricyclics and first-generation antihistamines. Falls risk is raised by benzodiazepines, Z-drugs (zolpidem, zopiclone), antipsychotics and aggressive antihypertensives — "start low, go slow."
A key exam point: older adults have reduced muscle mass, so serum creatinine can look normal while renal function is significantly reduced . Always estimate creatinine clearance (Cockcroft-Gault) before dosing renally cleared, narrow-index drugs such as digoxin.
Hepatic and Renal Impairment Dosing Principles
There is no simple creatinine-clearance equivalent for the liver. Severity is graded clinically with the Child-Pugh score — bilirubin, albumin, INR, ascites and encephalopathy — classed A (mild), B (moderate) and C (severe). Principles: avoid hepatotoxic drugs, reduce doses of hepatically cleared agents (especially high-extraction drugs), and be cautious with sedatives and opioids, which can precipitate encephalopathy.
For renal impairment , remember the loading vs maintenance distinction:
Loading dose depends on the volume of distribution (loading dose = Vd × target concentration ÷ bioavailability), which is usually unchanged in renal impairment — so the loading dose is generally given in full.
Maintenance dose depends on clearance — it must be reduced, either by lowering each dose (small therapeutic window drugs) or extending the interval (concentration-dependent drugs such as aminoglycosides, hence extended-interval gentamicin).